These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 33946961)

  • 21. Low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diet in patients with diarrhea-predominant irritable bowel syndrome: A prospective, randomized trial.
    Goyal O; Batta S; Nohria S; Kishore H; Goyal P; Sehgal R; Sood A
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2107-2115. PubMed ID: 33464683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota and irritable bowel syndrome.
    Zhao Y; Zou DW
    J Dig Dis; 2023 May; 24(5):312-320. PubMed ID: 37458142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
    World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
    Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
    Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG.
    Pinto-Sanchez MI; Nardelli A; Borojevic R; De Palma G; Calo NC; McCarville J; Caminero A; Basra D; Mordhorst A; Ignatova E; Hansen S; Uhde M; Norman GL; Murray JA; Smecuol E; Armstrong D; Bai JC; Schuppan D; Collins SM; Alaedini A; Moayyedi P; Verdu EF; Bercik P
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2343-2352.e8. PubMed ID: 32827724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low FODMAP diet reduces gastrointestinal symptoms in irritable bowel syndrome and clinical response could be predicted by symptom severity: A randomized crossover trial.
    Algera JP; Demir D; Törnblom H; Nybacka S; Simrén M; Störsrud S
    Clin Nutr; 2022 Dec; 41(12):2792-2800. PubMed ID: 36384081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly
    Wu KQ; Sun WJ; Li N; Chen YQ; Wei YL; Chen DF
    Scand J Gastroenterol; 2019 Dec; 54(12):1419-1425. PubMed ID: 31765575
    [No Abstract]   [Full Text] [Related]  

  • 30. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome.
    Wahnschaffe U; Schulzke JD; Zeitz M; Ullrich R
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):844-50; quiz 769. PubMed ID: 17553753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track.
    Rinninella E; Cintoni M; Raoul P; Gasbarrini A; Mele MC
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33260947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
    Ahluwalia B; Iribarren C; Magnusson MK; Sundin J; Clevers E; Savolainen O; Ross AB; Törnblom H; Simrén M; Öhman L
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.
    El-Salhy M; Hatlebakk JG; Hausken T
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31394793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal-Associated Microbiota Other Than Luminal Microbiota Has a Close Relationship With Diarrhea-Predominant Irritable Bowel Syndrome.
    Yang M; Hong G; Jin Y; Li Y; Li G; Hou X
    Front Cell Infect Microbiol; 2020; 10():515614. PubMed ID: 33224895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics.
    Staudacher HM; Scholz M; Lomer MC; Ralph FS; Irving PM; Lindsay JO; Fava F; Tuohy K; Whelan K
    Clin Nutr; 2021 Apr; 40(4):1861-1870. PubMed ID: 33183883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irritable bowel syndrome and gut microbiota.
    Canakis A; Haroon M; Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):28-35. PubMed ID: 31789724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet.
    Ciriza de Los Ríos C; Aparicio Cabezudo M; Zatarain Vallés A; Rey E
    Rev Esp Enferm Dig; 2022 Aug; 114(8):481-488. PubMed ID: 35694883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym.
    Catassi G; Lionetti E; Gatti S; Catassi C
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28300773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.
    Luo M; Liu Q; Xiao L; Xiong LS
    J Health Popul Nutr; 2022 May; 41(1):21. PubMed ID: 35578355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.